BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36595529)

  • 1. SARS-CoV-2 replicates and displays oncolytic properties in clear cell and papillary renal cell carcinoma.
    Choong OK; Jakobsson R; Bergdahl AG; Brunet S; Kärmander A; Waldenström J; Arvidsson Y; Altiparmak G; Nilsson JA; Karlsson J; Nyström K; Johansson ME
    PLoS One; 2023; 18(1):e0279578. PubMed ID: 36595529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
    Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
    J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
    Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
    Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells.
    Kroll MK; Schloer S; Candan P; Korthals N; Wenzel C; Ihle H; Gilhaus K; Liedtke KR; Schöfbänker M; Surmann B; Schröter R; Neugebauer U; Mall G; Oswald S; Ludwig S; Rescher U; Vollenbröker B; Ciarimboli G
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
    Matsuyama S; Nagata N; Shirato K; Kawase M; Takeda M; Taguchi F
    J Virol; 2010 Dec; 84(24):12658-64. PubMed ID: 20926566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells.
    Majidipur A; Morin-Dewaele M; Gaspar Lopes J; Berry F; Fouchet J; Bartier S; Dufros Duval A; Soyeux P; Huet E; Louis B; Coste A; Béquignon É; Saldana C; Le Corvoisier P; Destouches D; Pawlotsky JM; de la Taille A; Vacherot F; Bruscella P; Firlej V
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
    Roehrich H; Yuan C; Hou JH
    Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
    Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
    Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
    Gkogkou E; Barnasas G; Vougas K; Trougakos IP
    Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants.
    Chang CW; Parsi KM; Somasundaran M; Vanderleeden E; Liu P; Cruz J; Cousineau A; Finberg RW; Kurt-Jones EA
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19.
    Yang W; Li L; Zhang K; Ma K; Xie H; Gong Y; Zhou J; Gong K
    Int J Biol Sci; 2021; 17(1):20-31. PubMed ID: 33390830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.
    Dong M; Zhang J; Ma X; Tan J; Chen L; Liu S; Xin Y; Zhuang L
    Biomed Pharmacother; 2020 Nov; 131():110678. PubMed ID: 32861070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells.
    Peng J; Sun J; Zhao J; Deng X; Guo F; Chen L
    J Transl Med; 2021 Aug; 19(1):358. PubMed ID: 34412632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.
    Sakaguchi W; Kubota N; Shimizu T; Saruta J; Fuchida S; Kawata A; Yamamoto Y; Sugimoto M; Yakeishi M; Tsukinoki K
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
    Cantuti-Castelvetri L; Ojha R; Pedro LD; Djannatian M; Franz J; Kuivanen S; van der Meer F; Kallio K; Kaya T; Anastasina M; Smura T; Levanov L; Szirovicza L; Tobi A; Kallio-Kokko H; Österlund P; Joensuu M; Meunier FA; Butcher SJ; Winkler MS; Mollenhauer B; Helenius A; Gokce O; Teesalu T; Hepojoki J; Vapalahti O; Stadelmann C; Balistreri G; Simons M
    Science; 2020 Nov; 370(6518):856-860. PubMed ID: 33082293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.